Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Artificial Life|May 23, 2024
Self-Organization and Phase Transitions in Driven Cellular AutomataJ Hank RainwaterJournal of the American College of Radiology : JACR|February 20, 2019
Poor Uptake of Lung Cancer Screening: Opportunities for ImprovementMatthew Triplette, J Hank Thayer, Sudhakar N Pipavath, et al.Scandinavian Journal of Immunology|January 1, 1980
Family of large surface proteins on human lymphocytesB Koller, B Dunlap, J Hank, et al.Cellular Immunology|June 1, 1994
Human peripheral gamma delta T cells are stimulated by Daudi Burkitt's lymphoma and not by any other Burkitt's lymphoma testedI Kaur, J de Jong, K Schell, et al.Seminars in Musculoskeletal Radiology|March 30, 2019
Radiologic Evaluation of Lower Leg, Ankle, and Foot Fracture Fixation HardwareWinnie A Mar, J Hank Schilling, Laurie Lomasney, et al.Journal of the National Cancer Institute|March 2, 1988
Repetitive weekly cycles of recombinant human interleukin-2: responses of renal carcinoma with acceptable toxicityJ A Sosman, P C Kohler, J Hank, et al.Cancer Gene Therapy|June 9, 2007
Intratumoral injection of IL-12 plasmid DNA--results of a phase I/IB clinical trialD M Mahvi, M B Henry, M R Albertini, et al.ACS Applied Materials & Interfaces|May 7, 2024
Manufacturing Autoclave-Grade Thermoset Carbon Fiber-Reinforced Polymer Aerospace Composites without an Autoclave Using Nanoporous MaterialsCarina Xiaochen Li, Travis J Hank, Estelle Kalfon-Cohen, et al.Human Gene Therapy|May 1, 1997
Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcomaD M Mahvi, P M Sondel, N S Yang, et al.Cancer Research|March 15, 1993
A direct comparison of immunological and clinical effects of interleukin 2 with and without interferon-alpha in humansJ H Schiller, J Hank, B Storer, et al.Pageof 2